投稿
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
102 いいね5 低評価10 リポスト1 コメント
?
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
Moderna stock jumped 130% following a successful human trial for its skin cancer vaccine. The treatment proved effective even for late-stage melanoma patients.
2w
まだコメントはありません。最初のコメントを投稿しましょう！
コメント
まだコメントはありません。最初のコメントを投稿しましょう！